Disruptive Pharma AB (publ) (STO:DPHA)
Sweden · Delayed Price · Currency is SEK 1.398
-0.002 (-0.14%)
At close: Aug 26, 2026
Disruptive Pharma AB Company Description
Disruptive Pharma Holding Ab (Publ) operates as a pharmaceutical technology company that develops and commercializes patented platform technology for the formulation and development of pharmaceutical products.
The company was incorporated in 2021 and is based in Uppsala, Sweden.
Disruptive Pharma AB (publ)
| Country | Sweden |
| Founded | 2021 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Peter Åsberg |
Contact Details
Address: Dag Hammarskjölds Väg 54B Uppsala, 751 83 Sweden | |
| Website | disruptivepharma.com |
Stock Details
| Ticker Symbol | DPHA |
| Exchange | Nasdaq Stockholm |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Åsberg | Chief Executive Officer |
| Karin Botha | Chief Financial Officer |